Erratum for Mesplède et al., “The R263K Dolutegravir Resistance-Associated Substitution Progressively Decreases HIV-1 Integration”

Ítems similars

• The R263K Dolutegravir Resistance-Associated Substitution Progressively Decreases HIV-1 Integration
  per: Mesplède, Thibault, et al.
  Publicat: (2017)
• Combination of the R263K and M184I/V Resistance Substitutions against Dolutegravir and Lamivudine Decreases HIV Replicative Capacity
  per: Singhroy, Diane N., et al.
  Publicat: (2015)
• Polymorphic substitution E157Q in HIV-1 integrase increases R263K-mediated dolutegravir resistance and decreases DNA binding activity
  per: Anstett, Kaitlin, et al.
  Publicat: (2016)
• Dolutegravir Resistance Mutation R263K Cannot Coexist in Combination with Many Classical Integrase Inhibitor Resistance Substitutions
  per: Anstett, Kaitlin, et al.
  Publicat: (2015)
• The R263K mutation in HIV integrase that is selected by dolutegravir may actually prevent clinically relevant resistance to this compound
  per: Wainberg, Mark, et al.
  Publicat: (2014)